Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

被引:0
|
作者
Eissa, Eman [1 ]
Morcos, Botros [1 ]
Dorgham, Dalia [2 ]
Kholoussi, Naglaa [1 ]
机构
[1] Natl Res Ctr, Dept Immunogenet, Cairo, Egypt
[2] Cairo Univ, Fac Med, Dept Rheumatol & Rehabil, Cairo, Egypt
关键词
Complement factor H; factor H autoantibodies; juvenile-onset systemic lupus erythematosus; nephritis; DISEASE-ACTIVITY; BINDING-SITES; ACTIVATION; PRODUCTS; CRITERIA; INDEX;
D O I
10.46497/ArchRheumatol.2022.9217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls. Patients and methods: Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age: 26 +/- 7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset =16 years) (2 males, 63 females; mean age: 23.4 +/- 7 years; range, 15 to 38 years) were included. Factor H expression pattern was examined in blood of all subjects using quantitative real-time polymerase chain reaction and the frequency of factor H autoantibodies was estimated in plasma using enzyme-linked immunosorbent assay. Results: Factor H expression was significantly downregulated in jSLE patients compared to healthy controls (p<0.01). A significant underexpression of factor H was observed in jSLE patients with nephritis compared to those without nephritis (p<0.03), while there was no association of factor H expression levels with any of the other clinical and serological features, disease activity or disease damage index of patients. Only 5% of jSLE patients were positive for factor H autoantibodies without any correlations with the clinical data or disease activity of patients. Conclusion: Our study results suggest that factor H expression can be dysregulated in jSLE patients.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 50 条
  • [1] Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus
    Mina, Rina
    Klein-Gitelman, Marisa S.
    Nelson, Shannen
    Eberhard, B. Anne
    Higgins, Gloria
    Singer, Nora G.
    Onel, Karen
    Tucker, Lori
    O'Neil, Kathleen M.
    Punaro, Marilynn
    Levy, Deborah M.
    Haines, Kathleen
    Martini, Alberto
    Ruperto, Nicolino
    Lovell, Daniel
    Brunner, Hermine I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (02) : 401 - 406
  • [2] Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
    Chiewchengchol, Direkrit
    Murphy, Ruth
    Edwards, Steven W.
    Beresford, Michael W.
    PEDIATRIC RHEUMATOLOGY, 2015, 13
  • [3] Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients
    Chiewchengchol, Direkrit
    Murphy, Ruth
    Morgan, Thomas
    Edwards, Steven W.
    Leone, Valentina
    Friswell, Mark
    Pilkington, Clarissa
    Tullus, Kjell
    Rangaraj, Satyapal
    McDonagh, Janet E.
    Gardner-Medwin, Janet
    Wilkinson, Nick
    Riley, Phil
    Tizard, Jane
    Armon, Kate
    Sinha, Manish D.
    Ioannou, Yiannis
    Mann, Rebecca
    Bailey, Kathryn
    Davidson, Joyce
    Baildam, Eileen M.
    Pain, Clare E.
    Cleary, Gavin
    McCann, Liza J.
    Beresford, Michael W.
    RHEUMATOLOGY, 2014, 53 (08) : 1504 - 1512
  • [4] From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus
    Lim, Lily S. H.
    Pullenayegum, Eleanor
    Lim, Lillian
    Gladman, Dafna
    Feldman, Brian
    Silverman, Earl
    ARTHRITIS CARE & RESEARCH, 2017, 69 (11) : 1627 - 1635
  • [5] Low disease activity state in juvenile-onset systemic lupus erythematosus
    Ozturk, Kubra
    Caglayan, Sengul
    Tanatar, Ayse
    Baglan, Esra
    Otar, Gulcin Yener
    Kayaalp, Gulsah Kavrul
    Karadag, Serife Gul
    Demir, Ferhat
    Sonmez, Hafize Emine
    Ozdel, Semanur
    Cakan, Mustafa
    Ayaz, Nuray Aktay
    Sozeri, Betul
    LUPUS, 2021, 30 (13) : 2144 - 2150
  • [6] Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus
    El Garf, Kamal
    Marzouk, Huda
    Farag, Yomna
    Rasheed, Laila
    El Garf, Ayman
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1535 - 1540
  • [7] Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus
    Kamal El Garf
    Huda Marzouk
    Yomna Farag
    Laila Rasheed
    Ayman El Garf
    Rheumatology International, 2015, 35 : 1535 - 1540
  • [8] Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus
    Park, Su Jin
    Ahn, Moon Bae
    Jeong, Dae Chul
    FRONTIERS IN MEDICINE, 2025, 12
  • [9] Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus
    Liphaus, Bernadete L.
    Kiss, Maria Helena B.
    Carrasco, Solange
    Palmeira, Patricia
    Goldenstein-Schainberg, Claudia
    Carneiro-Sampaio, Magda
    CLINICAL RHEUMATOLOGY, 2017, 36 (12) : 2847 - 2852
  • [10] The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus
    Midgley, Angela
    McLaren, Zoe
    Moots, Robert J.
    Edwards, Steven W.
    Beresford, Michael W.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (08): : 2390 - 2401